Trial Profile
A dose-investigating study of AFM11 for the treatment of Non-Hodgkin's lymphoma
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 23 May 2015
Price :
$35
*
At a glance
- Drugs AFM 11 (Primary)
- Indications Non-Hodgkin's lymphoma
- Focus Adverse reactions
- 23 May 2015 New trial record
- 21 May 2015 According to an Affimed Therapeutics media release, this trial is expected to be initiated in early 2016.